Abstract
Background
Early elective medical abortion is performed frequently in different countries of the world. Serious complications like gestational trophoblastic neoplasia (GTN) are uncommon and mostly nonmetastatic. High risk metastatic GTN following medical abortion is a rare event which may occur coincidentally.
Case
A 26 year-old-woman, gravida 2 para 1, 6 weeks after misoprostol abortion presented with sever nausea, vomiting, and right upper abdominal pain. Human chorionic gonadotropin (hCG) level was 2,500,000 mIU/ml and metastatic work up revealed multiple liver metastases. She totally received nine cycles of EMA-CO (ethoposide- methotrexate- actinomycin- cyclophosphamide, vincristine) regimen for treatment and consolidation. Six months after treatment she is in complete remission.
Conclusion
Follow up of patients after medical abortion by means of single serum hCG measurement is highly recommended for early diagnosis of complications including gestational trophoblastic tumor. EMA-CO regimen seems to be an effective and safe treatment for liver metastatic gestational trophoblastic neoplasia.
Similar content being viewed by others
References
Bakri YN, Subhi J, Amer M, Ezzat A, Sinner W, Tweijry A, Jabbar FA (1993) Liver metastases of gestational trophoblastic tumor. Gynecol Oncol Volume 48(1):110–113
Barnard DE, Woodward KT, Yancey SG, Weed JC Jr, Hammond CB (1986) Hepatic metastases of choriocarcinoma: a report of 15 patients. Gynecol Oncol 25(1):73–83. doi:10.1016/0090-8258(86)90067-3
Berkowitz RS, Goldstein DP (2005) Gestational trophoblastic Disease. In: Hoskins WJ, Perez CA, Young RC, Barakat R, Markman M, Randall M (eds) Principles and practice of gynecologic oncology, 4th edn. Lippincott Williams & Wilkins, Philadelphia
Escobar PF, Lurain JR, Singh DK, Bozorgi K, Fishman DA (2003) Treatment of high- risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. Gynecol Oncol 91(3):552. doi:10.1016/j.ygyno.2003.08.028
Fiala C, Safar P, Bygdeman M, Gemzell-Danielsson K (2003) Verifying the effectiveness of medical abortion; ultrasound versus hCG testing. Eur J Obstet Gynecol Reprod Biol 109(2):190–195. doi:10.1016/S0301-2115(03)00012-5
Hershman JM (2004) Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab 18(2):249–265. doi:10.1016/j.beem.2004.03.010
Jin L, Fan G, Yang X (2000) Clinical study of four cases with malignant gestational trophoblastic tumor after mifepristone abortion. Zhonghua Fu Chan Ke Za Zhi 35(12):733–735
Kato K, Mostafa MH, Mann K, Schindler AE, Hoermann R (2004) The human chorionic gonadotropin molecule from patients with trophoblastic diseases has a high thyrotropic activity but is less active in the ovary. Gynecol Endocrinol 18(5):269–277. doi:10.1080/09513590410001667247
Lichtenberg ES (2003) Gestational trophoblastic tumor after medical abortion. Obstet Gynecol 101(5 Pt 2):1137–1139. doi:10.1016/S0029-7844(03)00062-0
Lyon FA, Adcock LL (1980) Choriocarcinoma presenting as a complication of elective first trimester abortion. Minn Med 63(10):733–735
Paul M, Schaff E, Nichols M (2000) The roles of clinical assessment, human chorionic gonadotropin assays, and ultrasonography in medical abortion practice. Am J Obstet Gynecol 183(Suppl 2):s34–s43. doi:10.1067/mob.2000.108230
Soper JT, Mutch DG, Schink JC (2004) Diagnosis and treatment of gestational trophoblastic disease: ACOG practice Bulletin No. 53. Gynecol Oncol 93:575–585. doi:10.1016/j.ygyno.2004.05.013
Valenzuela CY (2003) Scientific ethics of therapeutic abortion. Rev Med Chil 131(5):562–568
Xiang Y, Yang X, Yang N, Chen C, Cao T, Song H (2000) Diagnosis and management of gestational trophoblastic tumor with liver metastases. Zhongguo UI Xue Ke Xue Yuan Xue Bao 22(1):41–43
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mousavi, S.A., Behnamfar, F. Gestational trophoblastic tumor with liver metastatsis after misoprostol abortion. Arch Gynecol Obstet 279, 587–590 (2009). https://doi.org/10.1007/s00404-008-0756-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-008-0756-7